Brandon Bell / Getty Images
- Walmart's US CEO recently discussed the impact weight loss drugs like Ozempic have had on sales.
- An analyst note from Morgan Stanley aims to clarify Walmart's remarks.
- Walmart told the analysts the small group of known customers who take the drugs spend more overall.
Walmart is trying to clarify the impact weight-loss drugs like Ozempic and Wegovy are actually having on its bottom line.